{"code":"R79.8","type":"code","title":"Other specified abnormal findings of blood chemistry","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["asymptomatic hyperuricemia (E79.0)","hyperglycemia NOS (R73.9)","hypoglycemia NOS (E16.2)","neonatal hypoglycemia (P70.3-P70.4)","specific findings indicating disorder of amino-acid metabolism (E70-E72)","specific findings indicating disorder of carbohydrate metabolism (E73-E74)","specific findings indicating disorder of lipid metabolism (E75.-)"],"excludes2":["abnormal findings on antenatal screening of mother (O28.-)","abnormalities of lipids (E78.-)","abnormalities of platelets and thrombocytes (D69.-)","abnormalities of white blood cells classified elsewhere (D70-D72)","coagulation hemorrhagic disorders (D65-D68)","diagnostic abnormal findings classified elsewhere - see Alphabetical Index","hemorrhagic and hematological disorders of newborn (P50-P61)"],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true},"sibling_codes":["R79.81","R79.82","R79.83","R79.89"],"inclusionTerms":[],"sibling_titles":{"code":"R79.89","title":"Other specified abnormal findings of blood chemistry","isBillable":true},"useAdditionalCode":["code to identify any retained foreign body, if applicable (Z18.-)"],"clinicalDefinition":"Other specified abnormal findings of blood chemistry is a non-billable ICD-10-CM category code (R79.8). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): asymptomatic hyperuricemia (E79.0); hyperglycemia NOS (R73.9); hypoglycemia NOS (E16.2); neonatal hypoglycemia (P70.3-P70.","officialDefinition":"Other specified abnormal findings of blood chemistry is a non-billable ICD-10-CM category code (R79.8). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): asymptomatic hyperuricemia (E79.0); hyperglycemia NOS (R73.9); hypoglycemia NOS (E16.2); neonatal hypoglycemia (P70.3-P70.4); specific findings indicating disorder of amino-acid metabolism (E70-E72); specific findings indicating disorder of carbohydrate metabolism (E73-E74); specific findings indicating disorder of lipid metabolism (E75.-). Excludes2 (not included here): abnormal findings on antenatal screening of mother (O28.-); abnormalities of lipids (E78.-); abnormalities of platelets and thrombocytes (D69.-); abnormalities of white blood cells classified elsewhere (D70-D72); coagulation hemorrhagic disorders (D65-D68); diagnostic abnormal findings classified elsewhere - see Alphabetical Index; hemorrhagic and hematological disorders of newborn (P50-P61). Use additional code: code to identify any retained foreign body, if applicable (Z18.-).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}